892 related items for PubMed ID: 33352473
21. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.
Caanen MR, Schouten NE, Kuijper EAM, van Rijswijk J, van den Berg MH, van Dulmen-den Broeder E, Overbeek A, van Leeuwen FE, van Trotsenburg M, Lambalk CB.
Hum Reprod; 2017 Jul 01; 32(7):1457-1464. PubMed ID: 28505246
[Abstract] [Full Text] [Related]
22. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H, Tanir HM, Yildiz Z.
Arch Gynecol Obstet; 2006 Jul 01; 274(4):227-32. PubMed ID: 16691383
[Abstract] [Full Text] [Related]
23. Pre-polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set.
Ganie MA, Rashid A, Baba MS, Zargar MA, Wani IA, Nisar S, Wani IA, Douhath S, Sriwastawa M, Geer MI, Asrar MM, Kutum R, Hassan S, Khan S, Rafi W, Bhat DA, Showkat W, Sahar T, Choh NA, Khurshid R, Mudassar S, Shah ZA, Shabir I, Sofi SA, Gupta N, Hafeez I, Sreenivas V.
Clin Endocrinol (Oxf); 2023 Dec 01; 99(6):566-578. PubMed ID: 37656656
[Abstract] [Full Text] [Related]
24. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features.
Welt CK, Gudmundsson JA, Arason G, Adams J, Palsdottir H, Gudlaugsdottir G, Ingadottir G, Crowley WF.
J Clin Endocrinol Metab; 2006 Dec 01; 91(12):4842-8. PubMed ID: 17003085
[Abstract] [Full Text] [Related]
25. Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus.
Codner E, Soto N, Lopez P, Trejo L, Avila A, Eyzaguirre FC, Iniguez G, Cassorla F.
J Clin Endocrinol Metab; 2006 Jun 01; 91(6):2250-6. PubMed ID: 16569737
[Abstract] [Full Text] [Related]
26. The early development of offspring born to women with polycystic ovary syndrome: Insights from a prospective birth cohort study in Southwestern China.
Cao Q, Wang R, Zhou R, Huang X, Li Y, Zhu H, Qiao X, Huang W.
Psychoneuroendocrinology; 2024 May 01; 163():106984. PubMed ID: 38340540
[Abstract] [Full Text] [Related]
27. Changes in circulating forms of anti-Muüllerian hormone and androgens in women with and without PCOS: a systematic longitudinal study throughout pregnancy.
Peigné M, Simon V, Pigny P, Mimouni NEH, Martin C, Dewailly D, Catteau-Jonard S, Giacobini P.
Hum Reprod; 2023 May 02; 38(5):938-950. PubMed ID: 36921289
[Abstract] [Full Text] [Related]
28. Adolescents diagnosed with polycystic ovary syndrome under the Rotterdam criteria but not meeting the diagnosis under the updated guideline.
Kim JJ, Hwang KR, Lee D, Kim S, Choi YM.
Hum Reprod; 2024 May 02; 39(5):1072-1077. PubMed ID: 38514450
[Abstract] [Full Text] [Related]
29. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
Farhadi-Azar M, Behboudi-Gandevani S, Rahmati M, Mahboobifard F, Khalili Pouya E, Ramezani Tehrani F, Azizi F.
Front Endocrinol (Lausanne); 2022 May 02; 13():825528. PubMed ID: 35299965
[Abstract] [Full Text] [Related]
30. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
Kaltsas GA, Korbonits M, Isidori AM, Webb JA, Trainer PJ, Monson JP, Besser GM, Grossman AB.
Clin Endocrinol (Oxf); 2000 Oct 02; 53(4):493-500. PubMed ID: 11012575
[Abstract] [Full Text] [Related]
31. Anogenital distance in children born of mothers with polycystic ovary syndrome: the Odense Child Cohort.
Glintborg D, Jensen RC, Schmedes AV, Brandslund I, Kyhl HB, Jensen TK, Andersen MS.
Hum Reprod; 2019 Oct 02; 34(10):2061-2070. PubMed ID: 31560039
[Abstract] [Full Text] [Related]
32. Association of classic and 11-oxygenated androgens with polycystic ovaries and menstrual cycle prolongation in infertile women with PCOS.
Ma C, Xu H, Zhang X, Feng G, Shi L, Su Y, Yang L, Zhao R, Qiao J.
Clin Chim Acta; 2023 Jul 01; 547():117440. PubMed ID: 37311505
[Abstract] [Full Text] [Related]
33. The regulation and signalling of anti-Müllerian hormone in human granulosa cells: relevance to polycystic ovary syndrome.
Dilaver N, Pellatt L, Jameson E, Ogunjimi M, Bano G, Homburg R, D Mason H, Rice S.
Hum Reprod; 2019 Dec 01; 34(12):2467-2479. PubMed ID: 31735954
[Abstract] [Full Text] [Related]
34. Maternal polycystic ovary syndrome and risk of neuropsychiatric disorders in offspring: prenatal androgen exposure or genetic confounding?
Cesta CE, Öberg AS, Ibrahimson A, Yusuf I, Larsson H, Almqvist C, D'Onofrio BM, Bulik CM, Fernández de la Cruz L, Mataix-Cols D, Landén M, Rosenqvist MA.
Psychol Med; 2020 Mar 01; 50(4):616-624. PubMed ID: 30857571
[Abstract] [Full Text] [Related]
35. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forman JL, Thuesen LL, Cohen A, Hougaard DM, Nyboe Andersen A.
Hum Reprod; 2014 Apr 01; 29(4):791-801. PubMed ID: 24435776
[Abstract] [Full Text] [Related]
36. Ultrasonographic criteria in the diagnosis of polycystic ovary syndrome: a systematic review and diagnostic meta-analysis.
Pea J, Bryan J, Wan C, Oldfield AL, Ganga K, Carter FE, Johnson LM, Lujan ME.
Hum Reprod Update; 2024 Jan 03; 30(1):109-130. PubMed ID: 37804097
[Abstract] [Full Text] [Related]
37. Efficacy and safety of anti-androgens in the management of polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
Alesi S, Forslund M, Melin J, Romualdi D, Peña A, Tay CT, Witchel SF, Teede H, Mousa A.
EClinicalMedicine; 2023 Sep 03; 63():102162. PubMed ID: 37583655
[Abstract] [Full Text] [Related]
38. Association of maternal polycystic ovary syndrome or anovulatory infertility with obesity and diabetes in offspring: a population-based cohort study.
Chen X, Koivuaho E, Piltonen TT, Gissler M, Lavebratt C.
Hum Reprod; 2021 Jul 19; 36(8):2345-2357. PubMed ID: 34046665
[Abstract] [Full Text] [Related]
39. The complex relationship between hypothalamic amenorrhea and polycystic ovary syndrome.
Wang JG, Lobo RA.
J Clin Endocrinol Metab; 2008 Apr 19; 93(4):1394-7. PubMed ID: 18230664
[Abstract] [Full Text] [Related]
40. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
Legro RS, Chiu P, Kunselman AR, Bentley CM, Dodson WC, Dunaif A.
J Clin Endocrinol Metab; 2005 May 19; 90(5):2571-9. PubMed ID: 15713728
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
